Overview
- NuScale reported a GAAP loss of 14 cents per share and $565,000 in revenue, both below analyst estimates, and the stock fell about 6.7% in late trading, according to Benzinga.
- The company said it ended the quarter with $1.0 billion in cash and investments, underscoring what it calls strong liquidity.
- Management attributed the year-over-year revenue decline to the lack of RoPower license revenue and the completion in late 2025 of Fluor’s engineering work, which left no comparable activity in 2026.
- Research and development costs rose by $3.7 million as teams advanced NuScale Power Module component readiness, while regulatory costs eased after SDA approval in May 2025.
- NuScale pointed to an expanded partnership with Framatome and progress with the Tennessee Valley Authority, and it noted it is the only small modular reactor design approved by the U.S. Nuclear Regulatory Commission.